Shares of Atossa Therapeutics (NASDAQ: ATOS) were trading more than 22% higher as of 1:06 p.m. EDT Tuesday. Two factors could be behind its sharp stock price gain. First, fund managers are likely buying shares ahead of Atossa's pending inclusion into the Russell 2000 and Russell 3000 indexes.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting